Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Novartis Near Buy Point; Earns Near-Best Overall Rating
In This Article:
Novartis saw its IBD SmartSelect Composite Rating jump to 96 Wednesday, out of a best=possible 99. The new score indicates that shares of the company, which is No. 1 in its industry group, are now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. Winning stocks often have a 95 or higher grade in the early stages of a new price run, so that's a good starting point when looking for the best stocks to buy and watch.
Terms and Privacy Policy